ACXP
Price
$3.23
Change
-$0.05 (-1.52%)
Updated
Dec 4, 11:12 AM (EDT)
Capitalization
6.84M
Intraday BUY SELL Signals
PCSA
Price
$0.27
Change
+$0.01 (+3.85%)
Updated
Dec 3 closing price
Capitalization
15.12M
Intraday BUY SELL Signals
Interact to see
Advertisement

ACXP vs PCSA

Header iconACXP vs PCSA Comparison
Open Charts ACXP vs PCSABanner chart's image
Acurx Pharmaceuticals
Price$3.23
Change-$0.05 (-1.52%)
Volume$100
Capitalization6.84M
Processa Pharmaceuticals
Price$0.27
Change+$0.01 (+3.85%)
Volume$736.74K
Capitalization15.12M
ACXP vs PCSA Comparison Chart in %
ACXP
Daily Signal:
Gain/Loss:
PCSA
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ACXP vs. PCSA commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACXP is a StrongBuy and PCSA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 04, 2025
Stock price -- (ACXP: $3.32 vs. PCSA: $0.26)
Brand notoriety: ACXP and PCSA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACXP: 4% vs. PCSA: 4%
Market capitalization -- ACXP: $6.84M vs. PCSA: $15.12M
ACXP [@Biotechnology] is valued at $6.84M. PCSA’s [@Biotechnology] market capitalization is $15.12M. The market cap for tickers in the [@Biotechnology] industry ranges from $117.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACXP’s FA Score shows that 1 FA rating(s) are green whilePCSA’s FA Score has 1 green FA rating(s).

  • ACXP’s FA Score: 1 green, 4 red.
  • PCSA’s FA Score: 1 green, 4 red.
According to our system of comparison, PCSA is a better buy in the long-term than ACXP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACXP’s TA Score shows that 4 TA indicator(s) are bullish while PCSA’s TA Score has 3 bullish TA indicator(s).

  • ACXP’s TA Score: 4 bullish, 4 bearish.
  • PCSA’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, ACXP is a better buy in the short-term than PCSA.

Price Growth

ACXP (@Biotechnology) experienced а -14.21% price change this week, while PCSA (@Biotechnology) price change was +5.90% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.32%. For the same industry, the average monthly price growth was +1.23%, and the average quarterly price growth was +54.93%.

Industries' Descriptions

@Biotechnology (+0.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PCSA($15.1M) has a higher market cap than ACXP($6.84M). PCSA YTD gains are higher at: -70.978 vs. ACXP (-79.607). ACXP has higher annual earnings (EBITDA): -10.05M vs. PCSA (-12.96M). PCSA has more cash in the bank: 6.94M vs. ACXP (6.06M). PCSA has less debt than ACXP: PCSA (25.6K) vs ACXP (66.5K). ACXP (0) and PCSA (0) have equivalent revenues.
ACXPPCSAACXP / PCSA
Capitalization6.84M15.1M45%
EBITDA-10.05M-12.96M78%
Gain YTD-79.607-70.978112%
P/E RatioN/AN/A-
Revenue00-
Total Cash6.06M6.94M87%
Total Debt66.5K25.6K260%
TECHNICAL ANALYSIS
Technical Analysis
ACXPPCSA
RSI
ODDS (%)
Bullish Trend 7 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 7 days ago
86%
Bullish Trend 7 days ago
77%
Momentum
ODDS (%)
N/A
Bearish Trend 7 days ago
90%
MACD
ODDS (%)
N/A
Bearish Trend 7 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 7 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 7 days ago
90%
Advances
ODDS (%)
Bullish Trend 24 days ago
77%
Bullish Trend 7 days ago
85%
Declines
ODDS (%)
Bearish Trend 9 days ago
90%
Bearish Trend 14 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 7 days ago
82%
N/A
Aroon
ODDS (%)
Bearish Trend 7 days ago
88%
Bearish Trend 7 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ACXP
Daily Signal:
Gain/Loss:
PCSA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ACGL92.69-0.46
-0.50%
Arch Capital Group Ltd
BVFL18.18-0.13
-0.71%
BV Financial
VALN8.77-0.14
-1.57%
Valneva SE
CWK16.31-0.32
-1.92%
Cushman & Wakefield Ltd.
WVVI2.85-0.08
-2.68%
Willamette Valley Vineyards

ACXP and

Correlation & Price change

A.I.dvisor tells us that ACXP and XBIO have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ACXP and XBIO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACXP
1D Price
Change %
ACXP100%
-7.52%
XBIO - ACXP
30%
Poorly correlated
N/A
MGTX - ACXP
30%
Poorly correlated
-1.21%
OTLK - ACXP
29%
Poorly correlated
-1.08%
ATAI - ACXP
29%
Poorly correlated
+0.78%
FDMT - ACXP
29%
Poorly correlated
-3.71%
More

PCSA and

Correlation & Price change

A.I.dvisor indicates that over the last year, PCSA has been loosely correlated with INO. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if PCSA jumps, then INO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PCSA
1D Price
Change %
PCSA100%
-3.93%
INO - PCSA
38%
Loosely correlated
-0.52%
ONCO - PCSA
35%
Loosely correlated
-6.06%
BOLT - PCSA
30%
Poorly correlated
+0.62%
ACXP - PCSA
28%
Poorly correlated
-7.52%
EDIT - PCSA
28%
Poorly correlated
-3.65%
More